Volitionrx (VNRX) FCF Margin Growth (1y) (2020 - 2025)
Volitionrx (VNRX) FCF Margin Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 194.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 66.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 119.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 1,788.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -395.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 112.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -505.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -473.00 |
| 10 | Volitionrx | 1.13 Mn | -1.66 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 309,800.00 |
| Sep 30, 2025 | 78,153.00 |
| Jun 30, 2025 | -17,519.00 |
| Mar 31, 2025 | 323,261.00 |
| Dec 31, 2024 | -1.42 Mn |
| Sep 30, 2024 | 484,750.00 |
| Jun 30, 2024 | 121,555.00 |
| Mar 31, 2024 | 107,596.00 |
| Dec 31, 2023 | 326,543.00 |
| Sep 30, 2023 | 2.97 Mn |
| Jun 30, 2023 | 1.35 Mn |
| Mar 31, 2023 | -910,576.00 |
| Dec 31, 2022 | 3.82 Mn |
| Sep 30, 2022 | -1.62 Mn |
| Jun 30, 2022 | 555,631.00 |
| Mar 31, 2022 | 2.91 Mn |
| Dec 31, 2021 | 2.43 Mn |
| Sep 30, 2021 | 77.72 Mn |
| Jun 30, 2021 | 8.05 Mn |
| Mar 31, 2021 | 79.53 Mn |